Compare IDYA & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IDYA | NWN |
|---|---|---|
| Founded | 2015 | 1859 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 2019 | 2018 |
| Metric | IDYA | NWN |
|---|---|---|
| Price | $34.91 | $49.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 3 |
| Target Price | $52.86 | ★ $54.33 |
| AVG Volume (30 Days) | ★ 1.2M | 257.6K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.71% |
| EPS Growth | ★ 61.90 | 36.45 |
| EPS | N/A | ★ 2.33 |
| Revenue | $218,710,000.00 | ★ $1,289,363,000.00 |
| Revenue This Year | N/A | $11.37 |
| Revenue Next Year | $201.05 | $4.46 |
| P/E Ratio | ★ N/A | $20.90 |
| Revenue Growth | ★ 3024.43 | 11.83 |
| 52 Week Low | $20.50 | $39.29 |
| 52 Week High | $39.28 | $55.99 |
| Indicator | IDYA | NWN |
|---|---|---|
| Relative Strength Index (RSI) | 69.60 | 51.04 |
| Support Level | $32.85 | $48.30 |
| Resistance Level | $36.01 | $50.17 |
| Average True Range (ATR) | 1.80 | 1.08 |
| MACD | 0.67 | 0.12 |
| Stochastic Oscillator | 92.17 | 64.80 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in three reportable business segments, which are NWN Gas Utility, SiEnergy, and NWN Water. The company generates maximum revenue from NWN Gas Utility segment. It also generates revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.